PHARMACOGENOMIC STRATEGIES FOR THE PREVENTION OF ANTHRACYCLINE-INDUCED HEART FAILURE: A CODING VARIANT IN RARG CONFERS SUSCEPTIBILITY TO ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN CHILDHOOD CANCER

被引：0
|
作者：
Ross, Colin [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC, Canada
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2017年 / 32卷 / 01期
关键词：
D O I：
10.1016/j.dmpk.2016.10.292
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P166
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [1] A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
    Folefac Aminkeng
    Amit P Bhavsar
    Henk Visscher
    Shahrad R Rassekh
    Yuling Li
    Jong W Lee
    Liam R Brunham
    Huib N Caron
    Elvira C van Dalen
    Leontien C Kremer
    Helena J van der Pal
    Ursula Amstutz
    Michael J Rieder
    Daniel Bernstein
    Bruce C Carleton
    Michael R Hayden
    Colin J D Ross
    Nature Genetics, 2015, 47 : 1079 - 1084
  • [2] A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
    Aminkeng, Folefac
    Bhavsar, Amit P.
    Visscher, Henk
    Rassekh, Shahrad R.
    Li, Yuling
    Lee, Jong W.
    Brunham, Liam R.
    Caron, Huib N.
    van Dalen, Elvira C.
    Kremer, Leontien C.
    van der Pal, Helena J.
    Amstutz, Ursula
    Rieder, Michael J.
    Bernstein, Daniel
    Carleton, Bruce C.
    Hayden, Michael R.
    Ross, Colin J. D.
    NATURE GENETICS, 2015, 47 (09) : 1079 - +
  • [3] Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer
    Aminkeng, Folefac
    Ross, Colin J. D.
    Rassekh, Shahrad R.
    Rieder, Michael J.
    Bhavsar, Amit P.
    Sanatani, Shubhayan
    Bernstein, Daniel
    Hayden, Michael R.
    Amstutz, Ursula
    Carleton, Bruce C.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (05) : 1143 - 1145
  • [4] Pharmacogenomic Strategies for the Prevention of Anthracycline-Induced Heart Failure: Validation of a Genetic Association with a Non-Synonymous Variant in RARG
    Bhavsar, A. P.
    Rassekh, S. R.
    Aminkeng, F.
    Li, Y.
    Gunaretnam, E.
    Rieder, M. J.
    Bernstein, D.
    Hayden, M. R.
    Carleton, B. C.
    Ross, C. J. D.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S24 - S24
  • [5] Prevention of Anthracycline-Induced Cardiotoxicity
    Vejpongsa, Pimprapa
    Yeh, Edward T. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (09) : 938 - 945
  • [6] Anthracycline-induced chronic cardiotoxicity and heart failure
    Appel, Jon M.
    Nielsen, Dorte
    Zerahn, Bo
    Jensen, Benny V.
    Skagen, Knud
    ACTA ONCOLOGICA, 2007, 46 (05) : 576 - 580
  • [7] Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
    Visscher, Henk
    Ross, Colin J. D.
    Rassekh, S. Rod
    Barhdadi, Amina
    Dube, Marie-Pierre
    Al-Saloos, Hesham
    Sandor, George S.
    Caron, Huib N.
    van Dalen, Elvira C.
    Kremer, Leontien C.
    van der Pal, Helena J.
    Brown, Andrew M. K.
    Rogers, Paul C.
    Phillips, Michael S.
    Rieder, Michael J.
    Carleton, Bruce C.
    Hayden, Michael R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (13) : 1422 - 1428
  • [8] Anthracycline-induced cardiotoxicity in children with cancer: Strategies for prevention and management
    Iarussi D.
    Indolfi P.
    Casale F.
    Martino V.
    Di Tullio M.T.
    Calabrò R.
    Pediatric Drugs, 2005, 7 (2) : 67 - 76
  • [9] Anthracycline-induced cardiotoxicity
    Ozdogru, Ibrahim
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2014, 42 (03): : 274 - 276
  • [10] Anthracycline-Induced Cardiotoxicity
    Bannister, Clare
    Kuhnl, Andrea
    Potter, Victoria
    McDonagh, Theresa
    Kassam, Shireen
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 115 - 116
12345